Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-06

Clinical Trial Update: "Phase I / II Study on Infusion of Natural Killer Cells After Haploidentical Transplantation in Pediatric Patients" [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating infusion of natural killer cells after haploidentical transplantation in pediatric patients with high-risk leukemias; the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Natural killer cell infusion

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: High-risk Leukemias | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING